Moderate riskFDA DrugClass II

Ajanta Pharma fenofibrate capsules recalled for CGMP deviations

Ajanta Pharma USA Inc. is recalling one lot of fenofibrate 200 mg capsules due to manufacturing quality deviations discovered during inspection. The affected lot (PA02216, expiring 12/2029) was distributed nationwide.

From the FDA notice · Read the official notice ↗ · All Ajanta Pharma recalls

What to do

  1. Check your medication bottle for lot number PA02216 and expiration date 12/2029.
  2. Contact your pharmacy or doctor if you have this lot; do not stop taking fenofibrate without medical guidance.
  3. Return unused medication to your pharmacy for proper disposal.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
3648 bottles
Illnesses reported
None reported
Manufactured in
400 Crossing Blvd Ste 102, N/A, Bridgewater, NJ, United States
Classification
Class II
Recall number
D-0611-2026

In the FDA's words

Description
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04. CGMP Deviations Lot # PA02216; Exp. 12/2029 Distribution: U.S. Nationwide Affected quantity: 3648 bottles
Hazard
CGMP Deviations

More from Ajanta Pharma

See all

Related topics

OtherDrugsSold nationwideMore from FDA Drug